PROJECT

Projects

Summary of Advisory Services Project Information

Project Number

610473

Primary Business Area

Manufacturing, Agribusiness & Services

Disclosure Date

Mar 26, 2026

Country

Indonesia

Region

East Asia and the Pacific

IFC Approval Date

Jan 6, 2026

Status

Active

Estimated Total Budget

$61,552.00
(Project budget includes all project-funded activities)

Last Updated Date

Mar 30, 2026

Project Estimated Start Date

Jan 1, 2026

Project Estimated End Date

Jul 31, 2026

Client Legal Name

SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.

Project Description

IFC has partnered with Shanghai Fosun Pharmaceutical (Group) Co., Ltd. under an Upstream Engagement Letter to support the company's planned expansion in Asia, with a focus on aligning the company's investment plans with national healthcare priorities in target markets and strengthening local manufacturing and supply chains.

Development Results

E&S Risks / Impacts and Mitigation